Home reporting in C3G: a study for patients and caregivers
Part of Kidney & urinary clinical trials.
This study uses a smartphone app to track health information from people with C3G (a rare kidney disease) and their caregivers. It aims to collect real-world data to better understand the condition, no matter what treatments you are on.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with C3G (a kidney condition called complement 3 glomerulopathy).
- You are an adult (18 or older) who either has C3G or is caring for an adult or child with C3G.
- You can understand and agree to take part in the study.
- You have a smartphone or tablet to use the study app.
- You live in the United States and can read English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called OMS906 for people with C3G or ICGN (immune-related kidney diseases). It aims to see if the drug is safe and can reduce kidney damage. You may qualify if you have a confirmed diagnosis, high protein in your urine, and stable kidney function.
This study tests a new medicine called NM8074 for adults with C3 glomerulopathy, a kidney disease. The medicine may help reduce kidney damage. Participants will receive the study drug and be monitored for safety and effectiveness.
This study tests a smartphone app designed to help people with chronic kidney disease (CKD)—a condition where the kidneys don't filter blood as well as they should—follow the latest medical guidelines. The app aims to make it easier for younger adults to stay on top of their kidney health and treatment.
This study follows people in Russia with C3 glomerulopathy or IC-MPGN to understand how these kidney diseases progress over time. It does not test a new treatment, but gathers information from medical records and check-ups to learn more about the conditions.
This study tests a smartphone app designed to help people with advanced kidney disease (stage 5) manage their health at home. It may be a good fit if you have diabetes, kidney damage, or heart failure, and you are comfortable using an app on your phone or tablet.
This study tests a phone app (with check-ins on things like blood pressure and weight) to help prevent complications in people with advanced chronic kidney disease. You may be a good match if you’re high risk and can actively measure and share your health data with a kidney care team.
Hear when a new C3 Glomerulopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.